SPECIAL OPPORTUNITIES

A Note From Amanda: Below we have a sponsored message from Health Sciences Institute. They're supporting the Manward mission, so we hope you'll consider what they have to say.

[RFK Jr’s FINAL warning?] Prepare for 01/29/25

Dear Derek,

Mark your calendar and get ready...

RFK Jr's confirmation hearing is scheduled for Jan 29^th...

And all eyes will be on Capitol Hill.

Everyone from DC lobbyists to pharmaceutical CEOs are praying he doesn't expose THIS.

It's Big Pharma's biggest secret.

And hundreds of billions in profit and dark money political donations hang in the balance.

So you can bet Senators will be champing at the bit to smear, attack and undermine him at every turn...

They simply don't want THIS as a matter of public record.

But you can get a look at what he could reveal by clicking here now.

P.S. It doesn't matter whether you're a democrat or republican. What RFK Jr could be about to expose rises above politics and could just save your life. So click here now while this information is freely available online.

You are receiving this email because you subscribed to Manward Press Special Opportunities.

To stop receiving special invitations and offers from Manward Press Special Opportunities, please click here.
Please note: This will not impact the fulfillment of your subscription in any way.

Need help with your account? Click here. Have a question or comment for the editor? Click here.
Please do not reply to this email as it goes to an unmonitored inbox.

Manward Press, LLC | 14 West Mount Vernon Place | Baltimore, MD 21201

North America: 1.800.682.5210 | International: +1.443.353.4263
Website: manwardpress.com

Keep the emails you value from falling into your spam folder. Whitelist Manward Press Special Opportunities.

Nothing published by Manward Press, LLC should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation.

Any investments recommended by Manward Press, LLC should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Manward Press, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.